-transparent.png){kind=logo}
BACKGROUND Analgesia and sedation have been achieved noninvasively by fentanyl administration through the oral and nasal mucosa. In theory, the transmucosal bioavailability and absorption of fentanyl could be improved by converting more fentanyl to the unionized form by adjusting the surrounding pH. The authors tested this hypothesis in dogs. METHODS Under general anesthesia, each of six mongrel dogs was given fentanyl on repeated occasions, first intravenously (once), then by application to the buccal mucosa (six times). Buccal fentanyl administration was accomplished by placement of a pH-buffered solution of fentanyl into a specially constructed cell, which was clamped to the dog's buccal mucosa for 60 min. Fentanyl solutions with pHs of 6.6, 7.2, and 7.7 were studied to span a tenfold difference in the unionized fraction of fentanyl. Femoral arterial blood samples were sampled frequently and analyzed for fentanyl using a radioimmunoassay. Peak plasma concentration and the time of its occurrence for each buccal study were noted from the plasma concentration verses time profile. Terminal elimination half-life, bioavailability, and permeability coefficients were calculated using standard pharmacokinetic techniques. RESULTS The variables peak plasma concentration, bioavailability, and permeability coefficient increased three- to fivefold as the pH of the fentanyl buccal solution increased and more fentanyl molecules became unionized. There was no difference in terminal elimination half-life after intravenous fentanyl (244 +/- 68 min) or buccal fentanyl administration (pH 7.7, 205 +/- 89 min; pH 7.2, 205 +/- 65 min; pH 6.6, 196 +/- 48 min). In all buccal studies regardless of pH, time to peak plasma concentration occurred within 10 min of removal of the fentanyl solutions from the buccal mucosa. CONCLUSIONS The buccal absorption, bioavailability, and permeability of fentanyl are markedly increased as the pH of the fentanyl solution becomes more basic. Most likely, this is because of an increase in the fraction of unionized fentanyl.
J B Streisand, and
J Zhang, and
S Niu, and
S McJames, and
R Natte, and
N L Pace
November 2006,
Expert opinion on investigational drugs,
J B Streisand, and
J Zhang, and
S Niu, and
S McJames, and
R Natte, and
N L Pace
January 2008,
Drugs of today (Barcelona, Spain : 1998),
J B Streisand, and
J Zhang, and
S Niu, and
S McJames, and
R Natte, and
N L Pace
January 2007,
Clinical drug investigation,
J B Streisand, and
J Zhang, and
S Niu, and
S McJames, and
R Natte, and
N L Pace
May 2014,
Drug development and industrial pharmacy,
J B Streisand, and
J Zhang, and
S Niu, and
S McJames, and
R Natte, and
N L Pace
October 1971,
British journal of pharmacology,
J B Streisand, and
J Zhang, and
S Niu, and
S McJames, and
R Natte, and
N L Pace
July 1995,
Drug metabolism and disposition: the biological fate of chemicals,
J B Streisand, and
J Zhang, and
S Niu, and
S McJames, and
R Natte, and
N L Pace
January 1995,
European journal of clinical pharmacology,
J B Streisand, and
J Zhang, and
S Niu, and
S McJames, and
R Natte, and
N L Pace
October 1979,
Journal of pharmacokinetics and biopharmaceutics,
J B Streisand, and
J Zhang, and
S Niu, and
S McJames, and
R Natte, and
N L Pace
August 1996,
Pharmaceutical research,
J B Streisand, and
J Zhang, and
S Niu, and
S McJames, and
R Natte, and
N L Pace
June 2017,
Environmental science & technology,
